Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
AL-59412C for glaucoma and ocular hypertension
NCT01312454Phase 2Terminated
- Sponsor
- Alcon Inc.
- Start
- Jun 2011
- Primary completion
- Jan 2012
- Modality
- Small Molecules
01
Overview
A Phase 2 trial of AL-59412C in open-angle glaucoma (OAG), ocular hypertension, sponsored by Alcon Inc.. Started Jun 2011; status: terminated.
02
Drugs
AL-59412C
03
Conditions
open-angle glaucoma (OAG)ocular hypertension
Beyond the preview
Go deeper on NCT01312454.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT01312454.